Dry Eyes
14
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
1 terminated out of 14 trials
90.0%
+3.5% vs benchmark
14%
2 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Topical Menthol For Tear Secretion
Virgin Coconut Oil Contact Lens as Ocular Rewetting Agent
Examining the Immunological Process of Autoimmune Patients
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous Blood
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%
Effect of Contact Lens With Alginic Acid in Dry Eye Patients
Validating the Diagnostic Accuracy of Mediview 2.0 Software as an Image Analysis Tool of Meibomian Glands
Ocular Surface Dry Eye Microbiome
Dry Eye Symptoms and Quality of Life
Reproducibility of LipiView Ocular Surface Interferometer (LipiView) for Measuring Tear Lipid Layer Thickness
Reproducibility of Anterior Segment Optical Coherence Tomography (AS-OCT) for Imaging Conjunctivochalasis
Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics